Taking these data together, we could envisage a model (Fig. 6) in which a HFD would directly or indirectly provoke an increase in cardiac GRK2 levels in parallel with (or as a cause or consequence of) heart hypertrophy, fibrosis and steatosis. The gene discussed is GRK2; the disease is steatosis.